fbpx Skip to main content

Public Policy Newsletter Article

Newsom Announces State Workgroup to Review FDA Approved COVID-19 Vaccines

  • 2020-10-22T15:00:00.000+0000
  • Author: Jimmy Jackson

In a COVID-19 update briefing Monday, October 19, Governor Gavin Newsom announced that California was launching a Scientific Safety Review Workgroup to independently review FDA-approved vaccines. The group is intended as a review independent of the FDA for the safety, distribution and possible health effects for any approved vaccine administered in California.

This group is closely monitoring vaccine trials and is comprised of experts from across the state, with an emphasis on safety, equity and transparency in distribution of approved vaccines. The Governor acknowledged that there will be an extremely limited supply of vaccine available during initial distribution phases, and that supply would be prioritized for health care workers and first responders. Others who would be prioritized include healthcare facilities, age 65+ and those in long-term care, essential workers, those with a disability, racial ethnic minority groups, rural populations and incarcerated/detained individuals.

The state has submitted a draft plan to the CDC for distribution and administration of approved vaccines. In response to a reporter’s question at the announcement briefing, Governor Newsom affirmed that it his Administration’s position that any COVID-19 vaccine must be reviewed by the Workgroup before it may be administered in California.